Navigation Links
Clinilabs Welcomes Anesthesiologist Dr. Admir Hadzic Who Will Provide CSF/cCSF Capabilities For Clinilabs
Date:4/30/2013

NEW YORK, April 30, 2013 /PRNewswire-iReach/ -- Clinilabs, an early phase and specialty CRO that provides clinical drug development services to industry, today announced the arrival of Dr. Admir Hadzic to the Clinilabs team.  Dr. Hadzic will provide expertise in the development of drugs to treat pain, and also will manage the collection of CSF/cCSF samples in clinical trials.

Dr. Admir Hadzic has been at the forefront of academic anesthesiology for nearly two decades. His work has substantially contributed to the development of functional regional anesthesia anatomy, standardized techniques of nerve blocks, patient outcome benefits of regional anesthesia, and monitoring principles to standardize the practice and decrease the risk of complications of nerve blocks.  He has published numerous peer-reviewed articles and two leading textbooks, and is a founder of the global educational programs Networking World Anesthesia Convention and the New York School of Regional Anesthesia. Through these educational programs, Dr. Hadzic has trained physicians Worldwide in anesthesia techniques and other procedures such as CSF sampling. 

Dr. Gary Zammit , President and CEO of Clinilabs, states "Clinilabs is pleased to welcome Dr. Hadzic to our team.  He is a leader in the field of anesthesia who significantly broadens the capabilities we are able to offer our clients.  We look forward to his consultancy on multicenter pain trials that we manage, as well as his hands-on contribution to the trials being conducted at our NYC and NJ Phase I units that require anesthesia services." 

About Clinilabs Inc.

Clinilabs is a full-service contract research organization (CRO) that specializes in early-phase studies, from first-in-human to proof-of-concept, with normal healthy volunteers and patient populations.  The company owns and operates two Phase I units in the US, and maintains a network of highly qualified investigator sites for multicenter Phase II studies Worldwide.  Specialty projects, including pharmacodynamic, biomarker, cardiac safety, sleep/wakefulness, metabolic, and Japanese bridging are among our strengths.  Clinilabs is recognized globally as a leading specialty CRO, offering an alternative to large CROs for specialty projects.  For more information, please visit www.clinilabs.com.

Media Contact: Hannah DAoust , Clinilabs, 646-215-6480, hdaoust@clinilabs.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Clinilabs
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. EMBO welcomes 55 leading life scientists as members
2. FirstMark Welcomes Renowned Cardiologist and Researcher Dr. Prediman K. Shah to Scientific Advisor Board
3. FirstMark Welcomes Renowned Cardiologist and Researcher Dr. Prediman K. Shah to Scientific Advisory Board
4. The CNIO welcomes the new academic year with a spotlight on cancer genetics
5. Chiltern Welcomes Cedric Burg And James Gunter
6. Mayo Clinic anesthesiologist earns APSs Walter B. Cannon Award
7. Reproductive health providers should discuss environmental exposure risks with patients
8. Research on flavanols and procyanidins provides new insights into how these phytonutrients may positively impact human health
9. Artificial wetlands can provide benefits over the long haul
10. Discovery provides blueprint for new drugs that can inhibit hepatitis C virus
11. Heightened Security Threats and Economic Issues Provide Fillip to Global Civil and Military Biometrics Market, Says Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2018)... FREDERICK, Md. (PRWEB) , ... October 11, 2018 ... ... strong economy is the vision behind the National Institute for Innovation in Manufacturing ... an array of projects designed to advance biopharmaceutical manufacturing and workforce development in ...
(Date:10/5/2018)... Calif. (PRWEB) , ... October 04, 2018 , ... High ... of some of the tests such as cardiac troponin has serious clinical complications. There ... although the exact prevalence is still unknown. , High dose of biotin supplement ...
(Date:10/2/2018)... ... ... fun-loving eight-year-old Labrador retriever. Like many labs, Stuart’s favorite thing in the world is ... that whenever anyone comes to our door, he grabs a toy to greet them, just ... Stuart began limping and eventually could no longer play fetch. Though he was still ...
Breaking Biology News(10 mins):
(Date:10/2/2018)... ... October 02, 2018 , ... ... today announced a new out-of-the-box integration of the Genedata Bioprocess ® ... and laboratory equipment supplier. This enables the automatic import of raw instrument ...
(Date:10/2/2018)... ... October 02, 2018 , ... ... this week that teams have initiated validation of standards and testing of procedures ... direction of Dr. Larry Kennedy, ACRES VP for Quality Management Systems and Chief ...
(Date:9/28/2018)... ... September 28, 2018 , ... ... tech innovators, engineers, and scientists from around the world, is excited to announce ... of San Marcos, as the winner of the LabRoots Summer 2018 Textbook Scholarship, ...
(Date:9/27/2018)... ... September 26, 2018 , ... ... platform that aims to build the first human digitome, a digital representation of ... data through a seamless integration of all data sources. Dr. Michelle Longmire, Co-Founder ...
Breaking Biology Technology: